These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30681298)

  • 1. Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
    Yoshihisa A; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Takeishi Y
    ESC Heart Fail; 2019 Apr; 6(2):291-296. PubMed ID: 30681298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Neprilysin　- Cardiac Function and Outcome in Hypertrophic Cardiomyopathy.
    Yoshihisa A; Yokokawa T; Ichijo Y; Kimishima Y; Kanno Y; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Takeishi Y
    Circ Rep; 2019 May; 1(6):261-267. PubMed ID: 33693148
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.
    Lyle MA; Iyer SR; Redfield MM; Reddy YNV; Felker GM; Cappola TP; Hernandez AF; Scott CG; Burnett JC; Pereira NL
    JACC Heart Fail; 2020 Jan; 8(1):70-80. PubMed ID: 31392960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    Prins KW; Rose L; Archer SL; Pritzker M; Weir EK; Olson MD; Thenappan T
    J Am Heart Assoc; 2019 Jan; 8(2):e011464. PubMed ID: 30646788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study.
    Bayés-Genís A; Barallat J; Pascual-Figal D; Nuñez J; Miñana G; Sánchez-Mas J; Galan A; Sanchis J; Zamora E; Pérez-Martínez MT; Lupón J
    JACC Heart Fail; 2015 Aug; 3(8):641-4. PubMed ID: 26251092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.
    Nemcekova V; Malikova E; Goncalvesova E; Krenek P; Klimas J
    Bratisl Lek Listy; 2021; 122(1):28-33. PubMed ID: 33393317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right Atrial Function Predicts Clinical Outcome in Patients with Precapillary Pulmonary Hypertension.
    Mouratoglou SA; Dimopoulos K; Kamperidis V; Feloukidis C; Kallifatidis A; Pitsiou G; Stanopoulos I; Grosomanidis V; Hadjimiltiades S; Karvounis H; Giannakoulas G
    J Am Soc Echocardiogr; 2018 Oct; 31(10):1137-1145. PubMed ID: 30093146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.
    Choi IJ; Lim S; Hwang Y; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
    BMC Cardiovasc Disord; 2020 Aug; 20(1):360. PubMed ID: 32762650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Load Adaptability in Patients With Pulmonary Arterial Hypertension.
    Amsallem M; Boulate D; Aymami M; Guihaire J; Selej M; Huo J; Denault AY; McConnell MV; Schnittger I; Fadel E; Mercier O; Zamanian RT; Haddad F
    Am J Cardiol; 2017 Sep; 120(5):874-882. PubMed ID: 28705377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.
    Arrigo M; Vodovar N; Nougué H; Sadoune M; Pemberton CJ; Ballan P; Ludes PO; Gendron N; Carpentier A; Cholley B; Bizouarn P; Cohen-Solal A; Singh JP; Szymonifka J; Latremouille C; Samuel JL; Launay JM; Pottecher J; Richards AM; Truong QA; Smadja DM; Mebazaa A
    Eur Heart J; 2018 May; 39(20):1794-1798. PubMed ID: 29244074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension.
    Blumberg FC; Arzt M; Lange T; Schroll S; Pfeifer M; Wensel R
    Eur J Heart Fail; 2013 Jul; 15(7):771-5. PubMed ID: 23507788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative 3-Dimensional Echocardiography-Derived Right Ventricular Volumetric Analysis in Chronic Thromboembolic Pulmonary Hypertension Patients Before and After Pulmonary Thromboendarterectomy.
    Cronin B; O'Brien EO; Gu W; Banks D; Maus T
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1498-1503. PubMed ID: 30385197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Raeisi-Giglou P; Lam L; Tamarappoo BK; Newman J; Dweik RA; Tonelli AR
    Clin Cardiol; 2017 Jun; 40(6):356-363. PubMed ID: 28026030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Right Ventricular Afterload in COPD.
    Hilde JM; Skjørten I; Hansteen V; Melsom MN; Atar D; Hisdal J; Humerfelt S; Steine K
    COPD; 2016; 13(2):176-85. PubMed ID: 26914261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.